Abstract
A review of 498 patients treated with high-dose methotrexate (MTX) with citrovorum factor rescue revealed 29 drug-related deaths. Until the important factors in those deaths are identified, the use of high-dose MTX should be limited to institutions that possess the necessary supportive facilities and the ability to measure serum levels of the drug.
Original language | English (US) |
---|---|
Pages (from-to) | 745-748 |
Number of pages | 4 |
Journal | Cancer treatment reports |
Volume | 61 |
Issue number | 4 |
State | Published - Dec 1 1977 |
ASJC Scopus subject areas
- Oncology
- Cancer Research